Extraordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer’s Disease Treatment Options with Leaders and Experts on April 15th, 2021